Company news

Zhejiang Jianfeng Group Co. Ltd. news in 2025

Zhejiang Jianfeng Group Co. Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Announcement on Subsidiary's Passing GMP Compliance Inspection for Drugs

December 23, 2025

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025

November 21, 2025

Announcement on Obtaining Notice of Approval for Drug Clinical Trials by Subsidiary

November 14, 2025

Announcement on Convening the Q3 2025 Performance Briefing

November 3, 2025

Announcement on Canceling the Board of Supervisors and Amending the "Articles of Association" and Some Internal Control Systems

October 29, 2025

Announcement on Progress in Changes in Equity Structure of Indirect Controlling Shareholder

September 29, 2025

Announcement on Initially Repurchasing the Company's Shares through Call Auction

September 26, 2025

Announcement on Convening the 2025 Semi-annual Performance Briefing

September 19, 2025

Announcement on Obtaining Letter of Commitment for Special Loans for Stock Repurchase from Financial Institution

September 16, 2025

2025 Semi-annual Report

August 29, 2025

Indicative Announcement on Changes in Equity Structure of Indirect Controlling Shareholder

August 25, 2025

Announcement on Resolutions of the 11th Meeting of the 12th Board of Directors

August 15, 2025

Announcement on Adjusting Upper Limit of Shares Repurchase Price after Implementation Dividend Distribution for 2024

July 15, 2025

Announcement on Expected Increase in Semi-annual Performance for 2025

July 14, 2025

Announcement on Implementation of Dividend Distribution for 2024

July 8, 2025

Announcement on Resolution of the 1st Extraordinary General Meeting in 2025

June 27, 2025

Announcement on By-election of Director

June 11, 2025

Announcement on Progress in Providing Guarantees for Wholly-owned Subsidiaries

June 9, 2025

Announcement on Resolution of the 2024 Annual General Meeting

May 22, 2025

Announcement on the Retirement and Resignation of Deputy General Manager

May 16, 2025

Report for Q1 2025

April 29, 2025

Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders without Sales Limits Concerning Shares Repurchase

April 25, 2025

Announcement on Renewing Engagement of Accounting Firm

April 21, 2025

Announcement on Progress of Joint-stock subsidiary Tasly Pharmaceutical Group Co., Ltd. Selling Partial Equity

March 31, 2025

Announcement on Progress in Changing Equity Structure of Controlling Shareholder

January 24, 2025

Indicative Announcement on Changes in Equity Structure of Controlling Shareholder

January 21, 2025

Announcement on the Resolutions of the 6th Meeting of the 12th Board of Directors

January 3, 2025